http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-399575-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf3e43ca0b33d3d96af2df361d8cd9c3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G77-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
filingDate 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1ad4e7f25a37b6abe1254879877704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e38c55efd3e953f6e20ae692e70a58b
publicationDate 2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-399575-A1
titleOfInvention A method for producing linear silsesquioxanes with a regular structure
abstract The method of obtaining linear silsesquioxanes, especially silsesquioxanes with a ladder structure and formula in which R is a group selected from the group consisting of substituted or unsubstituted methyl, ethyl, propyl, butyl, isopropyl, sec-butyl, tert-butyl, vinyl, allyl or phenyl, especially halogen-substituted, amino, mercaptan, cyano, isocyanate, thiocyanate, n is a natural number from 1 to 100, consists in condensation reactions of a previously synthesized cyclic siloxane salt of formula 2, in which R has the above meaning, in the organic solvent solution, in the presence of a bissilylamine of the formula R "Me2SiNHSiMe2R", where R "is a substituent selected from the group consisting of hydrogen, methyl, ethyl, n-Pr, i-Pr, n-Bu, s-Bu, t -Bu, Ph, while Me is methyl.
priorityDate 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415844743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410442633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 31.